source
- Legend Biotech reports first in vivo CAR-T data from Chinese lymphoma trialLegend Biotech has released its first in vivo CAR-T cell therapy data, marking the next step after its CAR-T product Carvykti. The data come from an investigator-initiated trial in China that enro…
- Eli Lilly warns 340B hospitals to submit claims data within five days or lose price discountsEli Lilly has given roughly 50 hospitals that participate in the federal 340B drug discount program a five‑day deadline to provide comprehensive claims data. The company says that if the data are n…